James Wedner

Research output

Research output per year 1969 1978 1979 1980 1984 1985 1986 1987 1991 2019 2021 2023

• 111 Article
• 11 Review article
• 4 Letter
• 2 Comment/debate
• 1 More
  • 1 Editorial

Research output per year

Research output per year

Search results

• 2023

  Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses

  Ren, Z., Zhao, S., Li, T., Wedner, H. J. & Atkinson, J. P., Apr 2023, In: Journal of Allergy and Clinical Immunology. 151, 4, p. 1040-1049.e5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Complement C1 Inhibitor Protein 100%
  • Hereditary Angioedemas 92%
  • Recombinant Proteins 63%
  • Whole Genome Sequencing 18%
  • Whole Exome Sequencing 12%
  1 Scopus citations
• 2022

  Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study

  for the HELP OLE Investigators, Mar 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 3, p. 979-990 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lanadelumab 100%
  • Hereditary Angioedemas 66%
  • Therapeutics 7%
  • Injection Site Reaction 6%
  • Angioedema 6%
  15 Scopus citations

• SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

  Lin, F. J., Doss, A. M. A., Davis-Adams, H. G., Adams, L. J., Hanson, C. H., VanBlargan, L. A., Liang, C. Y., Chen, R. E., Monroy, J. M., Wedner, H. J., Kulczycki, A., Mantia, T. L., O’Shaughnessy, C. C., Raju, S., Zhao, F. R., Rizzi, E., Rigell, C. J., Dy, T. B., Kau, A. L., Ren, Z., & 10 othersTurner, J. S., O’Halloran, J. A., Presti, R. M., Fremont, D. H., Kendall, P. L., Ellebedy, A. H., Mudd, P. A., Diamond, M. S., Zimmerman, O. & Laidlaw, B. J., Dec 22 2022, In: Frontiers in immunology. 13, 1033770.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Primary Immunodeficiency Diseases 92%
  • Vaccination 54%
  • B-Lymphocytes 52%
  • Immunoglobulin G 51%
• 2021

  Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study

  on behalf of the HELP Study Investigators, Apr 2021, In: Allergy: European Journal of Allergy and Clinical Immunology. 76, 4, p. 1188-1198 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lanadelumab 100%
  • Hereditary Angioedemas 66%
  • Angioedema 30%
  • Quality of Life 29%
  • Placebos 16%
  20 Scopus citations

• Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

  SYNAPSE study investigators, Oct 2021, In: The Lancet Respiratory Medicine. 9, 10, p. 1141-1153 13 p.

  Research output: Contribution to journal › Article › peer-review

  • mepolizumab 100%
  • Nasal Polyps 77%
  • Placebos 41%
  • Nasal Obstruction 32%
  • Visual Analog Scale 24%
  174 Scopus citations

• Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

  Zuraw, B., Lumry, W. R., Johnston, D. T., Aygören-Pürsün, E., Banerji, A., Bernstein, J. A., Christiansen, S. C., Jacobs, J. S., Sitz, K. V., Gower, R. G., Gagnon, R., Wedner, H. J., Kinaciyan, T., Hakl, R., Hanzlíková, J., Anderson, J. T., McNeil, D. L., Fritz, S. B., Yang, W. H., Tachdjian, R., & 16 othersBusse, P. J., Craig, T. J., Li, H. H., Farkas, H., Best, J. M., Clemons, D., Cornpropst, M., Dobo, S. M., Iocca, H. A., Kargl, D., Nagy, E., Murray, S. C., Collis, P., Sheridan, W. P., Maurer, M. & Riedl, M. A., Jul 2021, In: Journal of Allergy and Clinical Immunology. 148, 1, p. 164-172.e9

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hereditary Angioedemas 100%
  • Placebos 48%
  • Plasma Kallikrein 15%
  • Research Personnel 13%
  • Back Pain 10%
  61 Scopus citations

• Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)

  Wedner, H. J., Aygören-Pürsün, E., Bernstein, J., Craig, T., Gower, R., Jacobs, J. S., Johnston, D. T., Lumry, W. R., Zuraw, B. L., Best, J. M., Iocca, H. A., Murray, S. C., Desai, B., Nagy, E., Sheridan, W. P. & Kiani-Alikhan, S., Jun 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 6, p. 2305-2314.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hereditary Angioedemas 100%
  • Safety 40%
  • Placebos 40%
  • Kallikreins 14%
  • Therapeutics 11%
  18 Scopus citations
• 2020

  Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter Survey

  Singh, U., Lumry, W. R., Busse, P., Wedner, H. J., Banerji, A., Craig, T. J., Li, H. H., Tachdjian, R., Jacobs, J. S., Riedl, M. A., Davis-Lorton, M., Christiansen, S. C., Zuraw, B. L. & Bernstein, J. A., Oct 2020, In: Journal of Allergy and Clinical Immunology: In Practice. 8, 9, p. 3162-3169.e5

  Research output: Contribution to journal › Article › peer-review

  • Hereditary Angioedemas 100%
  • Angioedema 90%
  • Oral Hygiene 79%
  • Tooth 50%
  • Dental Care 27%
  3 Scopus citations

• Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)

  Wedner, H. J., Nov 2020, In: Allergy and asthma proceedings. 41, 6, p. S14-S17

  Research output: Contribution to journal › Article › peer-review

  • Hereditary Angioedema Types I and II 100%
  • Hereditary Angioedemas 82%
  • Bradykinin 65%
  • Kallikreins 24%
  • Serine Proteases 21%
  19 Scopus citations

• Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks

  for the HELP Investigators, Nov 1 2020, In: Allergy: European Journal of Allergy and Clinical Immunology. 75, 11, p. 2879-2887 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lanadelumab 100%
  • Hereditary Angioedemas 66%
  • Placebos 19%
  • Hereditary Angioedema Types I and II 8%
  • Least-Squares Analysis 5%
  17 Scopus citations
• 2019

  Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study

  SAHARA study group, May 1 2019, In: Journal of Allergy and Clinical Immunology: In Practice. 7, 5, p. 1610-1618.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hereditary Angioedemas 100%
  • Placebos 48%
  • factor XIIa inhibitor 36%
  • Safety 17%
  • Hereditary Angioedema Types I and II 17%
  9 Scopus citations

• Immune globulin subcutaneous, human-klhw 20% for primary humoral immunodeficiency: An open-label, Phase III study

  Sleasman, J. W., Lumry, W. R., Hussain, I., Wedner, H. J., Harris, J. B., Courtney, K. L., Mondou, E., Lin, J. & Stein, M. R., 2019, In: Immunotherapy. 11, 16, p. 1371-1386 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Injection Site Reaction 100%
  • Immunoglobulins 95%
  • Pharmacokinetics 81%
  • Caprylates 65%
  • Safety 63%
  3 Scopus citations

• Impact of weather and climate change with indoor and outdoor air quality in asthma: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee

  Poole, J. A., Barnes, C. S., Demain, J. G., Bernstein, J. A., Padukudru, M. A., Sheehan, W. J., Fogelbach, G. G., Wedner, J., Codina, R., Levetin, E., Cohn, J. R., Kagen, S., Portnoy, J. M. & Nel, A. E., May 2019, In: Journal of Allergy and Clinical Immunology. 143, 5, p. 1702-1710 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Indoor Air Pollution 100%
  • Climate Change 94%
  • Weather 84%
  • Air Pollution 78%
  • Environmental Exposure 74%
  67 Scopus citations

• Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen

  Satyaraj, E., Wedner, H. J. & Bousquet, J., Oct 1 2019, In: Allergy: European Journal of Allergy and Clinical Immunology. 74, S107, p. 5-17 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Felis domesticus Fel d 1 protein 100%
  • 4-(N,N,N-trimethylamino)-2,2,6,6-tetramethylpiperidine-1-oxyl 97%
  • Cats 42%
  • Hypersensitivity 31%
  • IgY 17%
  33 Scopus citations

• Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit

  Solensky, R., Jacobs, J., Lester, M., Lieberman, P., McCafferty, F., Nilsson, T., Park, M., Schwarz, G., Soong, W., Wagelie-Steffen, A., Wedner, H. J., Weiss, M., Windom, H., Tonascia, J., Yates, K. P., Mendelson, L. M., Wolfe, J. & Adkinson, N. F., Jul 1 2019, In: Journal of Allergy and Clinical Immunology: In Practice. 7, 6, p. 1876-1885.e3

  Research output: Contribution to journal › Article › peer-review

  • Skin Tests 100%
  • Penicillins 99%
  • Hypersensitivity 80%
  • Amoxicillin 45%
  • Skin 22%
  41 Scopus citations
• 2018

  Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial

  Banerji, A., Riedl, M. A., Bernstein, J. A., Cicardi, M., Longhurst, H. J., Zuraw, B. L., Busse, P. J., Anderson, J., Magerl, M., Martinez-Saguer, I., Davis-Lorton, M., Zanichelli, A., Li, H. H., Craig, T., Jacobs, J., Johnston, D. T., Shapiro, R., Yang, W. H., Lumry, W. R., Manning, M. E., & 15 othersSchwartz, L. B., Shennak, M., Soteres, D., Zaragoza-Urdaz, R. H., Gierer, S., Smith, A. M., Tachdjian, R., Wedner, H. J., Hebert, J., Rehman, S. M., Staubach, P., Schranz, J., Baptista, J., Nothaft, W. & Maurer, M., Nov 27 2018, In: JAMA - Journal of the American Medical Association. 320, 20, p. 2108-2121 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • lanadelumab 100%
  • Hereditary Angioedemas 66%
  • Placebos 32%
  • Randomized Controlled Trials 31%
  • Hereditary Angioedema Types I and II 14%
  147 Scopus citations

• Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study

  Riedl, M. A., Aygören-Pürsün, E., Baker, J., Farkas, H., Anderson, J., Bernstein, J. A., Bouillet, L., Busse, P., Manning, M., Magerl, M., Gompels, M., Huissoon, A. P., Longhurst, H., Lumry, W., Ritchie, B., Shapiro, R., Soteres, D., Banerji, A., Cancian, M., Johnston, D. T., & 17 othersCraig, T. J., Launay, D., Li, H. H., Liebhaber, M., Nickel, T., Offenberger, J., Rae, W., Schrijvers, R., Triggiani, M., Wedner, H. J., Dobo, S., Cornpropst, M., Clemons, D., Fang, L., Collis, P., Sheridan, W. P. & Maurer, M., Sep 2018, In: Allergy: European Journal of Allergy and Clinical Immunology. 73, 9, p. 1871-1880 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hereditary Angioedemas 100%
  • Kallikreins 89%
  • Angioedema 56%
  • Placebos 48%
  • Plasma Kallikrein 26%
  24 Scopus citations
• 2017

  Inhibiting plasma kallikrein for hereditary angioedema prophylaxis

  Banerji, A., Busse, P., Shennak, M., Lumry, W., Davis-Lorton, M., Wedner, H. J., Jacobs, J., Baker, J., Bernstein, J. A., Lockey, R., Li, H. H., Craig, T., Cicardi, M., Riedl, M., Al-Ghazawi, A., Soo, C., Iarrobino, R., Sexton, D. J., Tenhoor, C., Kenniston, J. A., & 8 othersFaucette, R., Still, J. G., Kushner, H., Mensah, R., Stevens, C., Biedenkapp, J. C., Chyung, Y. & Adelman, B., Feb 23 2017, In: New England Journal of Medicine. 376, 8, p. 717-728 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Plasma Kallikrein 100%
  • lanadelumab 98%
  • Hereditary Angioedemas 94%
  • High Molecular Weight Kininogens 31%
  • Angioedema 19%
  121 Scopus citations

• Something new in the air: Paying for community-based environmental approaches to asthma prevention and control

  Tschudy, M. M., Sharfstein, J., Matsui, E., Barnes, C. S., Chacker, S., Codina, R., Cohn, J. R., Sandel, M. & Wedner, H. J., Nov 2017, In: Journal of Allergy and Clinical Immunology. 140, 5, p. 1244-1249 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Insurance Carriers 100%
  • Air 93%
  • Asthma 90%
  • Costs and Cost Analysis 72%
  • Fee-for-Service Plans 50%
  12 Scopus citations
• 2016

  Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

  Riedl, M. A., Bygum, A., Lumry, W., Magerl, M., Bernstein, J. A., Busse, P., Craig, T., Frank, M. M., Edelman, J., Williams-Herman, D., Feuersenger, H., Rojavin, M., Offenberger, J., Levy, R., Hurewitz, D., Li, H. H., Shapiro, R., Bernstein, J., Craig, T., Davis, A., & 27 othersRosch, J., Fox, J., Janss, G., Baker, J., Packer, F., Vegh, A., Frank, M., Sher, E., Busse, P., Wedner, J. H., Riedl, M., Lumry, W., Amrol, D., Gower, R., Silber, G., Portnoy, J., Paris, K., Darter, A., Mumneh, N., Petrov, A., Schneider, L., Martinez-Saguer, I., Staubach-Renz, P., Maurer, M., Bas, M., Aygören-Pürsün, E. & Wuillemin, W., Sep 1 2016, In: Journal of Allergy and Clinical Immunology: In Practice. 4, 5, p. 963-971 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hereditary Angioedemas 100%
  • Registries 55%
  • Safety 40%
  • Delivery of Health Care 21%
  • Self Administration 20%
  50 Scopus citations
• 2013

  Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease

  McMullan, K. L. & Wedner, H. J., Jan 2013, In: Clinical Cardiology. 36, 1, p. 25-30 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aspirin 100%
  • Hypersensitivity 88%
  • Cardiovascular Diseases 78%
  • Drug Hypersensitivity 72%
  • Safety 63%
  33 Scopus citations
• 2011

  Factors that predict the success of cyclosporine treatment for chronic urticaria

  Hollander, S. M., Joo, S. S. & Wedner, H. J., Dec 2011, In: Annals of Allergy, Asthma and Immunology. 107, 6, p. 523-528 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Urticaria 100%
  • Cyclosporine 70%
  • Urticaria 54%
  • Therapeutics 12%
  • Complementary Therapies 9%
  36 Scopus citations
• 2010

  Air filters and air cleaners: Rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee

  Sublett, J. L., Seltzer, J., Burkhead, R., Williams, P. B., Wedner, H. J. & Phipatanakul, W., Jan 2010, In: Journal of Allergy and Clinical Immunology. 125, 1-3, p. 32-38 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Air Filters 100%
  • Allergists 87%
  • Allergy and Immunology 64%
  • Allergens 57%
  • Air 48%
  84 Scopus citations
• 2006

  Elective penicillin skin testing in a pediatric outpatient setting

  Jost, B. C., Wedner, H. J. & Bloomberg, G. R., Dec 2006, In: Annals of Allergy, Asthma and Immunology. 97, 6, p. 807-812 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Skin Tests 100%
  • Penicillins 99%
  • penicilloic acid 86%
  • Outpatients 73%
  • Pediatrics 63%
  38 Scopus citations
• 2004

  Eosinophilia in an Iranian woman

  Mian, R. R., Ramos, M. S. & Wedner, H. J., Jun 2004, In: Annals of Allergy, Asthma and Immunology. 92, 6, p. 598-603 6 p.

  Research output: Contribution to journal › Article › peer-review
• 2000

  Deuteromycete aerobiology and skin-reactivity patterns: A two year concurrent study in Corpus Christi, Texas, USA

  Dixit, A., Lewis, W., Baty, J., Crozier, W. & Wedner, 2000, In: Grana. 39, 4, p. 209-218 10 p.

  Research output: Contribution to journal › Article › peer-review

  • aerobiology 100%
  • Deuteromycotina 81%
  • spore 60%
  • skin 53%
  • spores 48%
  15 Scopus citations
• 1999

  A randomized clinical trial to reduce asthma morbidity among inner-city children: Results of the national cooperative inner-city asthma study

  Evans, R., Gergen, P. J., Mitchell, H., Kattan, M., Kercsmar, C., Crain, E., Anderson, J., Eggleston, P., Malveaux, F. J. & Wedner, H. J., 1999, In: Journal of Pediatrics. 135, 3, p. 332-338 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Asthma 100%
  • Randomized Controlled Trials 86%
  • Morbidity 75%
  • Child 55%
  • Cetirizine 27%
  292 Scopus citations
• 1998

  Successful techniques for retention of study participants in an inner-city population

  Senturia, Y. D., McNiff Mortimer, K., Baker, D., Gergen, P., Mitchell, H., Joseph, C. & Wedner, H. J., Dec 1998, In: Controlled clinical trials. 19, 6, p. 544-554 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Interviews 100%
  • Population 58%
  • Social Support 41%
  • Contracts 25%
  • Diaries 22%
  88 Scopus citations
• 1997

  Characteristics of inner-city children with asthma: The National Cooperative Inner-City Asthma Study

  Kattan, M., Mitchell, H., Eggleston, P., Gergen, P., Crain, E., Redline, S., Weiss, K., Evans, R., Kaslow, R., Kercsmar, C., Leickly, F., Malveaux, F., Wedner, H. J. & Smartt, E., Oct 1 1997, In: Pediatric Pulmonology. 24, 4, p. 253-262 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Asthma 100%
  • Child 55%
  • Morbidity 45%
  • Epidemiologic Factors 19%
  • Hospitalization 19%
  49 Scopus citations

• Design and methods of the National Cooperative Inner-City Asthma Study

  Mitchell, H., Senturia, Y., Gergen, P., Baker, D., Joseph, C., McNiff-Mortimer, K., Wedner, H. J., Crain, E., Eggleston, P., Evans, R., Kattan, M., Kercsmar, C., Leickly, F., Malveaux, F., Smartt, E. & Weiss, K., Oct 1997, In: Pediatric Pulmonology. 24, 4, p. 237-252 16 p.

  Research output: Contribution to journal › Article › peer-review

  • Asthma 100%
  • Allergens 60%
  • Child 55%
  • Ambulatory Care 42%
  • Smoke 41%
  24 Scopus citations

• Psychosocial characteristics of inner-city children with asthma: A description of the NCICAS psychosocial protocol

  Wade, S., Weil, C., Holden, G., Mitchell, H., Evans, R., Kruszon-Moran, D., Bauman, L., Crain, E., Eggleston, P., Kattan, M., Kercsmar, C., Leickly, F., Malveaux, F., Wedner, H. J. & Smartt, E., Oct 1 1997, In: Pediatric Pulmonology. 24, 4, p. 263-276 14 p.

  Research output: Contribution to journal › Article › peer-review

  • Asthma 100%
  • Child 55%
  • Child Behavior 23%
  • Psychological Stress 21%
  • Social Adjustment 20%
  153 Scopus citations
• 1996

  Articulation of asthma and its care among low-income emergency care recipients

  Munro, J. F., Haire-Joshu, D., Fisher, E. B. & Wedner, H. J., 1996, In: Journal of Asthma. 33, 5, p. 313-325 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Emergency Medical Services 100%
  • Income 78%
  • Asthma 73%
  • Psychological Adaptation 13%
  • Self-Management 12%
  2 Scopus citations
• 1994

  Chronic fatigue syndrome: Point and counterpoint

  Straus, S. E., Komaroff, A. L. & Wedner, H. J., Jul 1994, In: Journal of Infectious Diseases. 170, 1, p. 1-6 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Fatigue Syndrome 100%
  • Centers for Disease Control and Prevention (U.S.) 40%
  • Routine Diagnostic Tests 36%
  • Communicable Diseases 33%
  • Psychiatry 29%
  25 Scopus citations
• 1993

  A comparison of patient attitudes toward asthma self-management among acute and preventive care settings

  Haire-Joshu, D., Fisher, E. B., Munro, J. & Wedner, H. J., 1993, In: Journal of Asthma. 30, 5, p. 359-371 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Preventive Medicine 100%
  • Self-Management 93%
  • Asthma 67%
  • Education 7%
  • Time-to-Treatment 6%
  21 Scopus citations
• 1992

  Grass aeropollen of the western United States Gulf Coast

  Lewis, W. H., Dixit, A. B. & Wednet, H. J., 1992, In: International Archives of Allergy and Immunology. 98, 1, p. 80-88 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Poaceae 100%
  • Pollen 94%
  • Droughts 11%
  • Rain 10%
  • Allergens 6%

• The allergens of Epicoccum nigrum link. I. Identification of the allergens by immunoblotting

  Dixit, A. B., Lewis, W. H. & Wedner, H. J., Jul 1992, In: The Journal of Allergy and Clinical Immunology. 90, 1, p. 11-20 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Immunoblotting 100%
  • Allergens 95%
  • Spores 87%
  • Mycelium 85%
  • Serum 46%
  22 Scopus citations
• 1991

  Aeropollen of weeds of the western United States Gulf Coast

  Lewis, W. H., Dixit, A. B. & Wedner, H. J., Jan 1 1991, In: Annals of Allergy. 67, 1, p. 47-52 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pollen 100%
  • Asteraceae 29%
  • North America 22%
  • Urticaceae 19%
  • Acalypha 19%
  2 Scopus citations

• Asteraceae aeropollen of the western United States Gulf Coast

  Lewis, W. H., Dixit, A. B. & Wedner, H. J., 1991, In: Annals of Allergy. 67, 1, p. 37-46 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Asteraceae 100%
  • Pollen 83%
  • Ambrosia 59%
  • Pollination 17%
  • ragweed pollen 8%
  7 Scopus citations

• Ritualistic use of the holly Ilex guayusa by Amazonian Jivaro Indians

  Lewis, W. H., Kennelly, E. J., Bass, G. N., Wedner, H. J., Elvin-Lewis, M. P. & W., D. F., 1991, In: Journal of Ethnopharmacology. 33, 1-2, p. 25-30 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Ilex guayusa 100%
  • Ilex 73%
  • Caffeine 47%
  • Dimethylxanthine 26%
  • Vomiting 24%
  31 Scopus citations

• The role of glutathione in lymphocyte activation- II. Effects of buthionine sulfoximine and 2-cyclohexene-1-one on early and late activation events

  Hamilos, D. L., Mascali, J. J. & Wedner, H. J., 1991, In: International Journal of Immunopharmacology. 13, 1, p. 75-90 16 p.

  Research output: Contribution to journal › Article › peer-review

  • cyclohexene 100%
  • Buthionine Sulfoximine 78%
  • Lymphocyte Activation 59%
  • Glutathione 50%
  • Lectins 41%
  26 Scopus citations
• 1990

  Aeropollen of herbaceous plants at Corpus Christi, Texas

  Lewis, W. H., Dixit, A. B. & Wedner, H. J., Dec 1990, In: Aerobiologia. 6, 2, p. 141-146 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Pollen 100%
  • herbaceous plants 97%
  • Asteraceae 79%
  • Poaceae 70%
  • pollen 65%
  1 Scopus citations

• Phytohemagglutinin rapidly lyses S49 T-lymphoma cells and the cytotoxicity is not mediated by generation of cAMP or increase in cytosolic calcium

  Gupta, A., Hruska, K. A. & Wedner, H. J., Aug 16 1990, In: Biochemical and Biophysical Research Communications. 170, 3, p. 1035-1043 9 p.

  Research output: Contribution to journal › Article › peer-review

  • T-Cell Lymphoma 100%
  • Phytohemagglutinins 97%
  • Calcium(0) 66%
  • Calcium 59%
  • Nicardipine 34%
  1 Scopus citations

• Recruitment workshop report

  Smith, T. & Wedner, J., Dec 1990, In: The Journal of Allergy and Clinical Immunology. 86, 6 PART 1, p. 965 1 p.

  Research output: Contribution to journal › Article › peer-review
• 1989

  Allergic reactivity to Parthenium hysterophorus pollen: An ELISA study of 582 sera from the United States Gulf Coast

  Wedner, H. J., Wilson, P. & Lewis, W. H., Aug 1989, In: The Journal of Allergy and Clinical Immunology. 84, 2, p. 263-271 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Ambrosia 100%
  • Pollen 80%
  • Parthenium hysterophorus extract 59%
  • Enzyme-Linked Immunosorbent Assay 48%
  • Accidental Falls 32%
  2 Scopus citations

• Facial swelling secondary to inhaled bronchodilator abuse: Catecholamine-induced sialadenosis

  Loria, R. C. & Wedner, H. J., Jan 1 1989, In: Annals of Allergy. 62, 4, p. 289-293 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Bronchodilator Agents 100%
  • Catecholamines 81%
  • Epinephrine 35%
  • Sarcoidosis 27%
  • gallium citrate 19%
  6 Scopus citations

• Identification of potential allergens in white oak (Quercus alba) pollen by immunoblotting

  Loria, R. C., Wilson, P. & Wedner, H. J., Jul 1989, In: The Journal of Allergy and Clinical Immunology. 84, 1, p. 9-18 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Quercus 100%
  • Pollen 70%
  • Immunoblotting 58%
  • Allergens 56%
  • Molecular Weight 41%
  10 Scopus citations

• Successful use of aztreonam in a patient who failed oral penicillin desensitization

  Loria, R. C., Finnerty, N. & Wedner, H. J., Apr 1989, In: The Journal of Allergy and Clinical Immunology. 83, 4, p. 735-737 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Aztreonam 100%
  • Penicillins 73%
  • Respiratory Sounds 53%
  • Monobactams 38%
  • Penicillin V 37%
  1 Scopus citations
• 1988

  Immunoblotting of pollen proteins: Tween 20 mediates nonspecific binding of gammaglobulins to immunoblots of oak-pollen proteins

  Loria, R. C., Prange, J. O. & Wedner, H. J., Nov 1988, In: The Journal of Allergy and Clinical Immunology. 82, 5 PART 1, p. 834-841 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Polysorbates 100%
  • Pollen 96%
  • Immunoblotting 80%
  • Collodion 42%
  • Detergents 34%
  2 Scopus citations
• 1987

  Allergic reactivity of Parthenium hysterophorus (Santa Maria feverfew) pollen: An unrecognized allergen

  Wedner, H. J., Zenger, V. E. & Lewis, W. H., Jan 1 1987, In: International Archives of Allergy and Applied Immunology. 84, 2, p. 116-122 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Tanacetum parthenium 100%
  • Radioallergosorbent Test 89%
  • Pollen 68%
  • Allergens 54%
  • austin 51%

• Allergic reactivity to Parthenium hysterophorus pollen: an unrecognized type I allergen.

  Wedner, H. J., Zenger, V. E. & Lewis, W. H., 1987, In: Experientia. Supplementum. 51, p. 125-130 6 p.

  Research output: Contribution to journal › Article › peer-review